Physician profile
Utpal Desai
NPI 1760478101
$106,277.79
in general payments reported to CMS, 2019-2025
30 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $10K · 2021: $1,361 · 2022: $7,699 · 2023: $7,632 · 2024: $41K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Travel and Lodging: $11K · Food and Beverage: $2,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,943.75 |
| Travel and Lodging | $11,006.49 |
| Food and Beverage | $2,775.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $72,840.11 | 2021-2025 | Corevalve Evolut R, Hawkone |
| Cardiovascular Systems INC. | $9,263.53 | 2019-2022 | |
| Medtronic Vascular, INC. | $7,347.38 | 2019-2020 | |
| Boston Scientific Corporation | $5,662.64 | 2020-2024 | Eluvia |
| Penumbra, INC. | $3,157.09 | 2019-2022 | |
| Edwards Lifesciences Corporation | $2,719.27 | 2020-2025 | Sapien 3 Ultra Resilia, Konect Resilia |
| Biom'Up Sa | $1,439.49 | 2019 | |
| Atricure, INC. | $1,027.08 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Abiomed | $934.77 | 2021-2025 | Impella |
| Cvrx, INC. | $449.46 | 2019-2025 | Barostim Neo System |
| Biom'Up France Sas | $271.91 | 2020 | |
| Dilon Technologies, INC. | $236.87 | 2023-2024 | Hemoblast Bellows |
| Abbott Laboratories | $180.77 | 2019-2021 | |
| Silk Road Medical, INC. | $113.35 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $106.52 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $72.00 | 2021 | |
| Terumo Medical Corporation | $71.66 | 2019 | |
| Zimmer Biomet Holdings, INC. | $47.03 | 2019-2020 | |
| Getinge USA Sales, LLC | $45.91 | 2023-2024 | Acrobat-I Stabilizer, Vasoview Hemopro 2 |
| Reel Surgical, INC. | $40.37 | 2023 | |
| Nuwellis, INC. | $38.18 | 2019 | |
| Ethicon INC. | $37.94 | 2020 | |
| Janssen Pharmaceuticals, INC | $31.36 | 2019 | |
| Kls-Martin L.P. | $30.71 | 2019-2020 | |
| Angiodynamics, INC. | $25.72 | 2019 | |
| Avinger INC. | $21.48 | 2019 | |
| Coherus Oncology, INC. | $19.77 | 2025 | Loqtorzi |
| Chiesi USA, INC. | $17.06 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.29 | 2023 | Artis Pheno |
| Ethicon US, LLC | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Utpal Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.